1 - 25 of 30 results for author:"Rimokh R." in Literature citations
Results Customize
› Repeat search in UniProtKB (16)
| Tif1gamma is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition. Hesling C., Lopez J., Fattet L., Gonzalo P., Treilleux I., Blanchard D., Losson R., Goffin V., Pigat N., Puisieux A. et al. Development 140:167-175(2013) · Mapped (18) |
| ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion. Vendrell J.A., Thollet A., Nguyen N.T., Ghayad S.E., Vinot S., Bieche I., Grisard E., Josserand V., Coll J.L., Roux P. et al. Cancer Res. 72:3593-3606(2012) · Mapped (4) |
| Dynamic regulation of Tgf-B signaling by Tif1gamma: a computational approach. Andrieux G., Fattet L., Le Borgne M., Rimokh R., Theret N. PLoS ONE 7:e33761-e33761(2012) · Mapped (19) |
| Antagonistic regulation of EMT by TIF1gamma and Smad4 in mammary epithelial cells. Hesling C., Fattet L., Teyre G., Jury D., Gonzalo P., Lopez J., Vanbelle C., Morel A.P., Gillet G., Mikaelian I. et al. EMBO Rep. 12:665-672(2011) · Mapped (6) |
| The NIP7 protein is required for accurate pre-rRNA processing in human cells. Morello L.G., Hesling C., Coltri P.P., Castilho B.A., Rimokh R., Zanchin N.I. Nucleic Acids Res. 39:648-665(2011) · Mapped (2) |
| Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Grelier G., Voirin N., Ay A.S., Cox D.G., Chabaud S., Treilleux I., Leon-Goddard S., Rimokh R., Mikaelian I., Venoux C. et al. Br. J. Cancer 101:673-683(2009) · Mapped (6) |
| Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. Vincent D.F., Yan K.P., Treilleux I., Gay F., Arfi V., Kaniewski B., Kaniewsky B., Marie J.C., Lepinasse F., Martel S. et al. PLoS Genet. 5:e1000575-e1000575(2009) · Mapped (17) |
| iNKT cell development is orchestrated by different branches of TGF-beta signaling. Doisne J.M., Bartholin L., Yan K.P., Garcia C.N., Duarte N., Le Luduec J.B., Vincent D., Cyprian F., Horvat B., Martel S. et al. J. Exp. Med. 206:1365-1378(2009) · Mapped (22) |
| Generation of mice with conditionally activated transforming growth factor beta signaling through the TbetaRI/ALK5 receptor. Bartholin L., Cyprian F.S., Vincent D., Garcia C.N., Martel S., Horvat B., Berthet C., Goddard-Leon S., Treilleux I., Rimokh R. et al. Genesis 46:724-731(2008) · Mapped (10) |
| BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling. Jeanpierre S., Nicolini F.E., Kaniewski B., Dumontet C., Rimokh R., Puisieux A., Maguer-Satta V. Blood 112:3154-3163(2008) · Mapped (2) |
| AF10-dependent transcription is enhanced by its interaction with FLRG. Forissier S., Razanajaona D., Ay A.S., Martel S., Bartholin L., Rimokh R. Biol. Cell 99:563-571(2007) · UniProtKB (2) |
| Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth. Razanajaona D., Joguet S., Ay A.S., Treilleux I., Goddard-Leon S., Bartholin L., Rimokh R. Cancer Res. 67:7223-7229(2007) · Mapped (1) |
| Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter. Bartholin L., Guindon S., Martel S., Corbo L., Rimokh R. Gene 393:153-162(2007) · Mapped (1) |
| A novel role for fibronectin type I domain in the regulation of human hematopoietic cell adhesiveness through binding to follistatin domains of FLRG and follistatin. Maguer-Satta V., Forissier S., Bartholin L., Martel S., Jeanpierre S., Bachelard E., Rimokh R. Exp. Cell Res. 312:434-442(2006) · UniProtKB (2) |
| AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner. Hayette S., Cornillet-Lefebvre P., Tigaud I., Struski S., Forissier S., Berchet A., Doll D., Gillot L., Brahim W., Delabesse E. et al. Cancer Res. 65:6521-6525(2005) · UniProtKB (2) |
| FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation. Bartholin L., Destaing O., Forissier S., Martel S., Maguer-Satta V., Jurdic P., Rimokh R. |
| FLRG, member of the follistatin family, a new player in hematopoiesis. Maguer-Satta V., Rimokh R. Mol. Cell. Endocrinol. 225:109-118(2004) · UniProtKB (1) |
| Follistatin-related gene expression, but not follistatin expression, is decreased in human endometrial adenocarcinoma. Ciarmela P., Florio P., Sigurdardottir M., Toti P., Maguer-Satta V., Rimokh R., Altomare A., Tosi P., Petraglia F. Eur. J. Endocrinol. 151:251-257(2004) · Mapped (7) |
| Human endometrium and decidua express follistatin-related gene (FLRG) mRNA and peptide. Florio P., Ciarmela P., Toti P., Maguer-Satta V., Rimokh R., Buonocore G., Rossi M., Gioffre W., Petraglia F. Mol. Cell. Endocrinol. 218:129-135(2004) · Mapped (1) |
| Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter. Baseggio L., Bartholin L., Chantome A., Charlot C., Rimokh R., Salles G. Eur. J. Immunogenet. 31:15-19(2004) · Mapped (6) |
| BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. Morel A.-P., Sentis S., Bianchin C., Le Romancer M., Jonard L., Rostan M.-C., Rimokh R., Corbo L. J. Cell Sci. 116:2929-2936(2003) · UniProtKB (2) · Mapped (4) |
| Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family. Maguer-Satta V., Bartholin L., Jeanpierre S., Ffrench M., Martel S., Magaud J.P., Rimokh R. Exp. Cell Res. 282:110-120(2003) · Mapped (8) |
| Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Bartholin L., Maguer-Satta V., Hayette S., Martel S., Gadoux M., Corbo L., Magaud J.P., Rimokh R. |
| AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14). Hayette S., Tigaud I., Vanier A., Martel S., Corbo L., Charrin C., Beillard E., Deleage G., Magaud J.-P., Rimokh R. Oncogene 19:4446-4450(2000) · UniProtKB (1) |
| FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Hayette S., Gadoux M., Martel S., Bertrand S., Tigaud I., Magaud J.-P., Rimokh R. Oncogene 16:2949-2954(1998) · UniProtKB (1) |